India is poised to be the one-stop solution for health, says Piyush Goyal

COVID-19 outbreak had made a major impact on the Indian healthcare sector but the ecosystem fought the pandemic back with innovations.

Friday February 26, 2021 , 2 min Read

The COVID-19 outbreak made a major impact on the Indian healthcare sector but the ecosystem fought back with innovations. While the pandemic helped in realising the gaps in healthcare, it also gave the opportunity to come up with new solutions.

Speaking at the sixth edition of ‘India Pharma & India Medical Device 2021,’ Cabinet Minister Piyush Goyal said that India has positioned itself as the go-to destination for healthcare majors.

“India is poised to be the one-stop solution for health,” he added.

S.Aparna, Dept of Pharma — *S.Aparna, Secretary of the Department of Pharmaceuticals [Image Credit: Twitter]*

ALSO READ

PLI scheme should lead India towards innovation: Amitabh Kant

Addressing the audience during the virtual event, S Aparna, Secretary of the Department of Pharmaceuticals, said that India is fortifying its position as a global leader in pharmaceutical and medical device manufacturing.

She added that the Indian pharmaceutical and medical device industry is working towards achieving the goal of “Make in India for the World”.

Reiterating the government’s commitment to ensure ease of doing business for global investors in the pharmaceutical and medical devices sectors, she said, “Government will provide stable, long-term policy environment to facilitate transformation of the sector.”

The event also saw the launch of the EY Report on Indian Pharmaceutical Industry 2021, which includes an analysis of the current scenario and future potential of the sector.

"Indian Pharma is poised to leverage its key role in the global supply chain for generics & transform into a more diversified & innovation driven industry"- Ms S Aparna, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India pic.twitter.com/vr1bQ5KCgb
— India Medical Device 2021 (@Indiamedicaldev) February 25, 2021

The pharmaceutical department secretary also informed that India has successfully supplied critical drugs and medical devices across the country without any disruption.

This comes in just a few days after the Union Cabinet approved the Production Linked Incentive (PLI) Scheme for pharmaceuticals for a period of FY 2020-21 to 2028-29.